-
Who benefits behind the scenes from high prescription drug prices?
If there’s one thing most Americans still agree on, it’s that the ever-increasing cost of healthcare is simply unsustainable. And while there is plenty of blame to go around, one must look at who benefits behind the scenes from inflated prices — particularly for prescription medications — to really understand the root of the problem.
-
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
-
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
-
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
-
Long-Term Care Pharmacies Say Negotiation Hurts Them Without PBM Reform
Long-term care pharmacies say the kick-off of Medicare drug price negotiation Tuesday (Aug. 29), while well-intentioned, will inadvertently hurt them and their patients unless policy makers also move forward on pharmacy benefit manager and Part D payment reforms. “Long term care pharmacies are likely to be collateral damage,” Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition, told Inside Health Policy.
-
SCPC Calls for Solutions that Protect Long-term Care Patients and Pharmacies as White House Announces Initial List for Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the Biden administration’s announcement of the first 10 drugs selected for Medicare price negotiations, eight of which are heavily utilized by patients served by long-term care pharmacies.
-
2023 SCPC Summit Recap
In late July, the Senior Care Pharmacy Coalition (SCPC) gathered in Washington, D.C. for our annual Business Partners Summit where we discussed key issues and policies impacting the long-term care (LTC) pharmacy community and the unique role our members play in America’s healthcare system.
View Archives
By Date
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)
- September 2023 (2)
- August 2023 (4)
- July 2023 (4)
- June 2023 (1)
- March 2023 (2)
- January 2023 (1)
- December 2022 (1)
- October 2022 (4)
- July 2022 (1)
- June 2022 (3)